PATENT CLAIM ANALYSIS

Application Number: 15911362
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["435", "006000"]

Abstract:
An influenza vaccine adjuvanted with a sub-micron oil-in-water emulsion elicits significantly higher immune responses in human pediatric populations. Compared to an existing unadjuvanted pediatric influenza vaccine, the adjuvanted vaccines provided herein can induce in children a longer persistence of high serum antibody titers and also longer seroconversion and seroprotection. The improvement in immune responses is seen for both influenza A virus and influenza B virus strains, but it is particularly marked for influenza B virus. Moreover, while the existing vaccine provides poor immunity in children after a single dose, the adjuvanted vaccine provides high seroprotection rates against the influenza A virus H3N2 subtype even after a single dose. Furthermore, the adjuvanted vaccine offers significantly better seroprotection against mismatched strains of influenza A virus.

Claim (Index 18):
A split or subunit influenza vaccine having a vaccine efficacy in children of at least 50%.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 90.0
- Lexical Diversity: 1.7973
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12378929', '13923642', '14996446', '13163002', '14465055']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6505489890848378
- 35 USC 102 Novelty (BERT): 0.5516935752718581
- Combined Prediction Score: 0.6406634477035398
- Mean Citation Score: 418.15825000000007
- Max Citation Score: 485.39243
- Similarity Product: 281.19752017996785

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test